Top

Published in:

01-08-2015 | PERSPECTIVES FROM JAPAN REVIEW ARTICLE

Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence

Authors: Keiichiro Yoshinaga, MD, PhD, FACC, Nagara Tamaki, MD, PhD

Published in: Journal of Nuclear Cardiology | Issue 4/2015

Abstract

Nuclear cardiology imaging tests are widely performed in Japan as clinical practice. The Japanese nuclear cardiology community has developed new diagnostic imaging tests using ¹²³I-beta-methyl-p-iodophenyl-pentadecanoic acid, ¹²³I-metaiodobenzylguanidine, and ¹⁸F-fluorodeoxyglucose PET for detecting cardiac involvement in sarcoidosis. These tests have become popular worldwide. The Japanese Circulation Society and the Japanese Society of Nuclear Cardiology have published clinical imaging guidelines showing indications and standards for the new imaging tests. JSNC is currently striving to improve the standard of clinical practice and is promoting research activities.

JCS Joint Working Group. Guidelines for clinical use of cardiac nuclear medicine (jcs, 2010)—digest version. Circ J 2010;2012:761-7.

Yoshinaga K. Updated health, labor and welfare ministry’s approval of cardiac positron emission tomography. Nucl Cardio 2013;15:31.

Ishida Y, Yoshinaga K, Miyagawa M, Moroi M, Kondoh C, Kiso K, et al. Recommendations for (18)f-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese society of nuclear cardiology recommendations. Ann Nucl Med 2014;28:393-403.CrossRefPubMed

Kinuya S, Kuwabara Y, Inoue K, Sakamoto S, Shimosegawa E, Takeoka K, et al. Nuclear medicine practice in japan: A report of the seventh nationwide survey in 2012. Ann Nucl Med 2014;28:1032-8.CrossRefPubMed

Tamaki N, Yoshinaga K. Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology. J Nucl Cardiol 2011;18:135-43.PubMedCentralCrossRefPubMed

Yoshinaga K, Naya M, Shiga T, Suzuki E, Tamaki N. Ischaemic memory imaging using metabolic radiopharmaceuticals: Overview of clinical settings and ongoing investigations. Eur J Nucl Med Mol Imaging 2014;41:384-93.CrossRefPubMed

Chikamori T, Yamashina A, Hida S, Nishimura T. Diagnostic and prognostic value of BMIPP imaging. J Nucl Cardiol 2007;14:111-25.CrossRefPubMed

Hashimoto J, Ogawa K, Bai J, Kubo A, Imai Y. Simultaneous dual-isotope imaging based on an artificial neural network for evaluating myocardial perfusion and fatty acid metabolism. J Nucl Cardiol 2013;20:396-405.CrossRefPubMed

Yoshinaga K, Tomiyama Y, Manabe O, Kasai K, Katoh C, Magota K, et al. Prone-position acquisition of myocardial (123)I-metaiodobenzylguanidine (MIBG) spect reveals regional uptake similar to that found using (11)C-hydroxyephedrine PET/CT. Ann Nucl Med 2014;28:761-9.CrossRefPubMed

10.

Thackeray JT, Bengel FM. Assessment of cardiac autonomic neuronal function using pet imaging. J Nucl Cardiol 2013;20:150-65.CrossRefPubMed

11.

Gulati V, Ching G, Heller GV. The role of radionuclide imaging in heart failure. J Nucl Cardiol 2013;20:1173-83.CrossRefPubMed

12.

Travin MI. Cardiac autonomic imaging with spect tracers. J Nucl Cardiol 2013;20:128-43; quiz 146

13.

Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Allergy 1967;16:178-222

14.

Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, et al. An atypical variant of fabry’s disease in men with left ventricular hypertrophy. N Engl J Med 1995;333:288-93.CrossRefPubMed

15.

Tsuchihashi K, Ueshima K, Uchida T, Oh-mura N, Kimura K, Owa M, et al. Transient left ventricular apical ballooning without coronary artery stenosis: A novel heart syndrome mimicking acute myocardial infarction. Angina pectoris-myocardial infarction investigations in japan. J Am Coll Cardiol 2001;38:11-8.CrossRefPubMed

16.

Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S. Circadian variation of exercise capacity in patients with prinzmetal’s variant angina: Role of exercise-induced coronary arterial spasm. Circulation 1979;59:938-48.CrossRefPubMed

17.

Moroi M, Tamaki N, Nishimura M, Haze K, Nishimura T, Kusano E, et al. Association between abnormal myocardial fatty acid metabolism and cardiac-derived death among patients undergoing hemodialysis: Results from a cohort study in Japan. Am J Kidney Dis 2013;61:466-75.CrossRefPubMed

18.

Nakata T, Nakajima K, Yamashina S, Yamada T, Momose M, Kasama S, et al. A pooled analysis of multicenter cohort studies of (123)I-MIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. JACC 2013;6:772-84.PubMed

19.

Ronan G, Wolk MJ, Bailey SR, Doherty JU, Douglas PS, Hendel RC, et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: A report of the American College of Cardiology Foundation appropriate use criteria task force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Nucl Cardiol 2014;21:192-220.CrossRefPubMed

20.

Chatterjee A, Hage FG. Guidelines in review: 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Nucl Cardiol 2015;22:158-61.CrossRefPubMed

21.

Anderson GF, Frogner BK. Health spending in OECD countries: Obtaining value per dollar. Health Aff 2008;27:1718-27.CrossRef

22.

Bengel FM, Higuchi T, Javadi MS, Lautamaki R. Cardiac positron emission tomography. J Am Coll Cardiol 2009;54:1-15.CrossRefPubMed

23.

Ishimaru S, Tsujino I, Takei T, Tsukamoto E, Sakaue S, Kamigaki M, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 2005;26:1538-43.CrossRefPubMed

24.

Ohira H, Tsujino I, Yoshinaga K. (1)(8)F-fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging 2011;38:1773-83.CrossRefPubMed

25.

Bateman TM. Advantages and disadvantages of PET and SPECT in a busy clinical practice. J Nucl Cardiol 2012;19:S3-11.CrossRefPubMed

26.

Dorbala S, Di Carli MF, Beanlands RS, Merhige ME, Williams BA, Veledar E, et al. Prognostic value of stress myocardial perfusion positron emission tomography: Results from a multicenter observational registry. J Am Coll Cardiol 2013;61:176-84.PubMedCentralCrossRefPubMed

27.

Yoshinaga K, Chow BJ, Williams K, Chen L, deKemp RA, Garrard L, et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol 2006;48:1029-39.CrossRefPubMed

28.

Katoh C, Yoshinaga K, Klein R, Kasai K, Tomiyama Y, Manabe O, et al. Quantification of regional myocardial blood flow estimation with three-dimensional dynamic rubidium-82 PET and modified spillover correction model. J Nucl Cardiol 2012;19:763-74.CrossRefPubMed

29.

Yoshinaga K, Katoh C, Manabe O, Klein R, Naya M, Sakakibara M, et al. Incremental diagnostic value of regional myocardial blood flow quantification over relative perfusion imaging with generator-produced rubidium-82 PET. Circ J 2011;75:2628-34.CrossRefPubMed

30.

Yoshinaga K, Klein R, Tamaki N. Generator-produced rubidium-82 positron emission tomography myocardial perfusion imaging-from basic aspects to clinical applications. J Cardiol 2010;55:163-73.CrossRefPubMed

31.

Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/ASNC Committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). J Am Coll Cardiol 2003;42:1318-33.CrossRefPubMed

32.

Gulenchyn KY, McEwan AJ, Freeman M, Kiess M, O’Neill BJ, Beanlands RS, et al. Treating the right patient at the right time: Access to cardiovascular nuclear imaging. Can J Cardiol 2006;22:827-33.PubMedCentralCrossRefPubMed

33.

Nishimura T, Nakajima K, Kusuoka H, Yamashina A, Nishimura S. Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-access study. Eur J Nucl Med Mole Imaging 2008;35:319-28.CrossRef

34.

Cerqueira MD, Allman KC, Ficaro EP, Hansen CL, Nichols KJ, Thompson RC, et al. Recommendations for reducing radiation exposure in myocardial perfusion imaging. J Nucl Cardiol 2010;17:709-18.CrossRefPubMed

35.

Matsumoto N, Suzuki Y, Nagao K, Hirayama A, Sato Y. Less invasive approach to the assessment of coronary artery disease. Morphological vs. Physiological paradigm. Circ J 2011;75:1573-4.CrossRefPubMed

36.

Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (courage) trial nuclear substudy. Circulation 2008;117:1283-91.CrossRefPubMed

37.

Nakajima K, Takeishi Y, Matsuo S, Yamasaki Y, Nishimura T. Metabolic syndrome is not a predictor for cardiovascular events in Japanese patients with diabetes mellitus asymptomatic for coronary artery disease: A retrospective analysis of the J-access-2 study. J Nucl Cardiol 2013;20:234-41.CrossRefPubMed

38.

Nakajima K, Matsuo S, Kawano M, Matsumoto N, Hashimoto J, Yoshinaga K, et al. The validity of multi-center common normal database for identifying myocardial ischemia: Japanese Society of Nuclear Medicine Working Group database. Ann Nucl Med 2010;24:99-105.CrossRefPubMed

39.

Nakajima K, Nakajima Y, Horikoshi H, Ueno M, Wakabayashi H, Shiga T, et al. Enhanced diagnostic accuracy for quantitative bone scan using an artificial neural network system: A Japanese Multi-Center database project. EJNMMI research. 2013;3:83.PubMedCentralCrossRefPubMed

40.

Yamauchi T, Tamaki N, Kasanuki H, Kimura T, Uemura Y, Iimuro S, et al. Optimal initial diagnostic strategies for the evaluation of stable angina patients: A multicenter, prospective study on myocardial perfusion imaging, computed tomographic angiography, and coronary angiography. Circ J 2012;76:2832-9.CrossRefPubMed

41.

Yoshinaga K, Matsuki T, Hashimoto A, Tsukamoto K, Nakata T, Tamaki N. Validation of automated quantitation of myocardial perfusion and fatty acid metabolism abnormalities on SPECT images. Circ J 2011;75:2187-95.CrossRefPubMed

42.

Nakata T, Miyamoto K, Sasao A, Wakabayashi T, Kobayashi H. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. J Nucl Cardiol 1998;5:579-90.CrossRefPubMed

43.

Koshino K, Watabe H, Enmi J, Hirano Y, Zeniya T, Hasegawa S, et al. Effects of patient movement on measurements of myocardial blood flow and viability in resting (1)(5)O-water pet studies. J Nucl Cardiol 2012;19:524-33.PubMedCentralCrossRefPubMed

44.

Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. Hrs expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11:1305-23.CrossRefPubMed

45.

Mc Ardle BA, Leung E, Ohira H, Cocker MS, deKemp RA, DaSilva J, et al. The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis. J Nucl Cardiol 2013;20:297-306.CrossRefPubMed

46.

Youssef G, Leung E, Mylonas I, Nery P, Williams K, Wisenberg G, et al. The use of 18F-FDG pet in the diagnosis of cardiac sarcoidosis: A systematic review and metaanalysis including the Ontario experience. J Nucl Med 2012;53:241-8.CrossRefPubMed

47.

Manabe O, Ohira H, Yoshinaga K, Sato T, Klaipetch A, Oyama-Manabe N, et al. Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis. Eur J Nucl Med Mol Imaging 2013;40:1558-66.CrossRefPubMed

48.

Manabe O, Yoshinaga K, Ohira H, Sato T, Tsujino I, Yamada A, et al. Right ventricular (18)F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis. Ann Nucl Med 2014;28:656-63.CrossRefPubMed

49.

Miyagawa M, Yokoyama R, Nishiyama Y, Ogimoto A, Higaki J, Mochizuki T. Positron emission tomography-computed tomography for imaging of inflammatory cardiovascular diseases. Circ J 2014;78:1302-10.CrossRefPubMed

50.

Tahara N, Tahara A, Nitta Y, Kodama N, Mizoguchi M, Kaida H, et al. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. JACC 2010;3:1219-28.PubMed

51.

Yazaki Y, Isobe M, Hiroe M, Morimoto S, Hiramitsu S, Nakano T, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001;88:1006-10.CrossRefPubMed

52.

Sarazawa K, Nakano A, Uzui H, Mitsuke Y, Geshi T, Okazawa H, et al. Acute hyperglycemia causes microvascular damage, leading to poor functional recovery and remodeling in patients with reperfused ST-segment elevation myocardial infarction. J Nucl Cardiol 2012;19:507-14.CrossRefPubMed

Title: Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence
Authors: Keiichiro Yoshinaga, MD, PhD, FACC
Nagara Tamaki, MD, PhD
Publication date: 01-08-2015
Publisher: Springer US
Published in: Journal of Nuclear Cardiology / Issue 4/2015
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-015-0136-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2015

Abstracts of Original Contributions ASNC2015 The 20th Annual Scientific Session of the American Society of Nuclear Cardiology

Imaging in patients after cardiac transplantation and in patients with ventricular assist devices

Health care policy and journal impact

Review of cardiovascular imaging in The Journal of Nuclear Cardiology in 2014: Part 2 of 2: Myocardial perfusion imaging

Dependence of left ventricular functional parameters on image acquisition time in cardiac-gated myocardial perfusion SPECT

The prognostic value of regadenoson stress: Has the case been made?